Cal-Maine Foods (CALM) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Dec, 2025Executive summary
Achieved record first quarter results with net sales up 17.4% year-over-year to $922.6 million, driven by growth in specialty eggs, prepared foods, and the Echo Lake Foods acquisition.
Specialty eggs and prepared foods now account for nearly 40% of net sales, reflecting a strategic shift toward value-added products and diversification.
Net income rose 32.9% to $199.3 million, with diluted EPS up 34.6% to $4.12.
Vertical integration, operational excellence, and disciplined capital allocation are emphasized as competitive advantages.
Echo Lake Foods acquisition exceeded expectations, contributing $70.5 million in revenue and accelerating growth in prepared foods.
Financial highlights
Net sales reached $922.6 million, up 17.4% year-over-year, with gross profit of $311.3 million (33.7% margin) and operating income of $249.2 million (27% margin).
Net income was $199.3 million ($4.12 per diluted share), up from $150 million ($3.06 per share) last year.
Operating cash flow surged 137.2% to $278.6 million from $117.5 million year-over-year.
Declared a cash dividend of $1.37 per share, payable November 13.
$500 million share repurchase program authorized, with $450 million remaining.
Outlook and guidance
Specialty eggs and prepared foods are expected to continue driving margin expansion and higher quality earnings.
Strategy focuses on expanding specialty/prepared foods, leveraging vertical integration, and disciplined M&A.
Ongoing investments in automation, cage-free capacity, and prepared foods expansion are planned.
Management expects continued volatility in egg and feed prices due to market and supply chain factors.
Sufficient liquidity and credit facilities are in place to fund operations and capital projects.
Latest events from Cal-Maine Foods
- Strong growth, disciplined M&A, and specialty focus drive market leadership amid supply challenges.CALM
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Specialty eggs and prepared foods drove nearly half of sales, supporting growth despite lower egg prices.CALM
Q2 20267 Jan 2026 - Shareholders will vote on directors, auditor ratification, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Proxy seeks approval for director elections, auditor ratification, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation changes.CALM
Proxy Filing2 Dec 2025 - Lower sales offset by acquisitions and sustainability focus amid HPAI challenges.CALM
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor, and officer exculpation amendment.CALM
Proxy Filing2 Dec 2025 - Record growth, acquisitions, and enhanced shareholder rights marked fiscal 2025.CALM
Proxy Filing2 Dec 2025 - Vote on director elections and auditor ratification at the October 2025 annual meeting.CALM
Proxy Filing2 Dec 2025